Home » Topics » Regulatory

Regulatory
RSS

FDA grants accelerated approval to Venclexta for newly diagnosed AML

Nov. 22, 2018

FDA approves Gamifant for primary hemophagocytic lymphohistiocytosis

Nov. 21, 2018

FDA approves Aemcolo for the treatment of travelers' diarrhea

Nov. 19, 2018

FDA grants approval for Adcetris as first-line treatment for peripheral T-cell lymphoma

Nov. 19, 2018

European Commission approves Cabometyx for HCC previously treated with sorafenib

Nov. 15, 2018

FDA approves Yupelri for maintenance treatment of COPD

Nov. 12, 2018

European Commission approves expanded label for Trelegy Ellipta in COPD

Nov. 9, 2018

FDA approves Bijuva for moderate to severe hot flashes due to menopause

Oct. 30, 2018

France becomes first country to market baclofen preparation to reduce alcohol consumption

Oct. 29, 2018

FDA approves Dupixent as add-on maintenance therapy for asthma

Oct. 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.